Skip to main content
. 2006 Aug 15;108(12):3674–3681. doi: 10.1182/blood-2006-02-005702

Table 2.

Patients with FLT3 mutations

Patient no. Tandutinib dose level, mg twice daily FLT3 mutation Hemizygous or homozygous
24 150 9 AA ITD after D600 Yes
52 300 13 AA ITD after D600 No
62 400* 33 AA ITD after F612 No
64 400 D835Y No
73 525 20 AA ITD after F612 No
74 525 58 AA ITD after F612 No
76 525 38 AA ITD after F612 Yes
82 700 7 AA ITD after D600 Yes
83 700 19 AA ITD after E608 Yes
*

Patient received only 1 dose of tandutinib.